Prevention of cervix cancer

Cheryl L. Rock, Claire W. Michael, R. Kevin Reynolds, Mack Ruffin

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

Cervix carcinoma is an important health problem world-wide, being the second most common cancer among women, ranking first in many developing countries. A number of important epidemiological risk factors have been identified as contributing to the development of CIN and invasive cervix carcinoma. Of key importance is infection with human papillomavirus (HPV), which is the primary risk factor. There are evolving primary and secondary preventive strategies that could further reduce the burden from cervical carcinoma. The possible primary preventive strategies include risk reduction, diet or dietary supplements, HPV vaccines, and other chemopreventive agents. The possible advances in secondary preventive strategies include new technologies for Pap smears, HPV typing triage, and other adjuvant screening procedures. The impact of these strategies will depend upon evidence to support their use along with the characteristics of the population and environment in which they are used. Copyright (C) 2000 Elsevier Science Ireland Ltd.

Original languageEnglish (US)
Pages (from-to)169-185
Number of pages17
JournalCritical Reviews in Oncology/Hematology
Volume33
Issue number3
DOIs
StatePublished - Jan 1 2000

Fingerprint

Uterine Cervical Neoplasms
Carcinoma
Cervix Uteri
Papanicolaou Test
Papillomavirus Vaccines
Triage
Population Characteristics
Risk Reduction Behavior
Dietary Supplements
Developing Countries
Diet
Technology
Infection
Neoplasms
Global Health

All Science Journal Classification (ASJC) codes

  • Hematology
  • Oncology
  • Geriatrics and Gerontology

Cite this

Rock, Cheryl L. ; Michael, Claire W. ; Reynolds, R. Kevin ; Ruffin, Mack. / Prevention of cervix cancer. In: Critical Reviews in Oncology/Hematology. 2000 ; Vol. 33, No. 3. pp. 169-185.
@article{f07858381f394821995c70821d283226,
title = "Prevention of cervix cancer",
abstract = "Cervix carcinoma is an important health problem world-wide, being the second most common cancer among women, ranking first in many developing countries. A number of important epidemiological risk factors have been identified as contributing to the development of CIN and invasive cervix carcinoma. Of key importance is infection with human papillomavirus (HPV), which is the primary risk factor. There are evolving primary and secondary preventive strategies that could further reduce the burden from cervical carcinoma. The possible primary preventive strategies include risk reduction, diet or dietary supplements, HPV vaccines, and other chemopreventive agents. The possible advances in secondary preventive strategies include new technologies for Pap smears, HPV typing triage, and other adjuvant screening procedures. The impact of these strategies will depend upon evidence to support their use along with the characteristics of the population and environment in which they are used. Copyright (C) 2000 Elsevier Science Ireland Ltd.",
author = "Rock, {Cheryl L.} and Michael, {Claire W.} and Reynolds, {R. Kevin} and Mack Ruffin",
year = "2000",
month = "1",
day = "1",
doi = "10.1016/S1040-8428(99)00073-6",
language = "English (US)",
volume = "33",
pages = "169--185",
journal = "Critical Reviews in Oncology/Hematology",
issn = "1040-8428",
publisher = "Elsevier Ireland Ltd",
number = "3",

}

Prevention of cervix cancer. / Rock, Cheryl L.; Michael, Claire W.; Reynolds, R. Kevin; Ruffin, Mack.

In: Critical Reviews in Oncology/Hematology, Vol. 33, No. 3, 01.01.2000, p. 169-185.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Prevention of cervix cancer

AU - Rock, Cheryl L.

AU - Michael, Claire W.

AU - Reynolds, R. Kevin

AU - Ruffin, Mack

PY - 2000/1/1

Y1 - 2000/1/1

N2 - Cervix carcinoma is an important health problem world-wide, being the second most common cancer among women, ranking first in many developing countries. A number of important epidemiological risk factors have been identified as contributing to the development of CIN and invasive cervix carcinoma. Of key importance is infection with human papillomavirus (HPV), which is the primary risk factor. There are evolving primary and secondary preventive strategies that could further reduce the burden from cervical carcinoma. The possible primary preventive strategies include risk reduction, diet or dietary supplements, HPV vaccines, and other chemopreventive agents. The possible advances in secondary preventive strategies include new technologies for Pap smears, HPV typing triage, and other adjuvant screening procedures. The impact of these strategies will depend upon evidence to support their use along with the characteristics of the population and environment in which they are used. Copyright (C) 2000 Elsevier Science Ireland Ltd.

AB - Cervix carcinoma is an important health problem world-wide, being the second most common cancer among women, ranking first in many developing countries. A number of important epidemiological risk factors have been identified as contributing to the development of CIN and invasive cervix carcinoma. Of key importance is infection with human papillomavirus (HPV), which is the primary risk factor. There are evolving primary and secondary preventive strategies that could further reduce the burden from cervical carcinoma. The possible primary preventive strategies include risk reduction, diet or dietary supplements, HPV vaccines, and other chemopreventive agents. The possible advances in secondary preventive strategies include new technologies for Pap smears, HPV typing triage, and other adjuvant screening procedures. The impact of these strategies will depend upon evidence to support their use along with the characteristics of the population and environment in which they are used. Copyright (C) 2000 Elsevier Science Ireland Ltd.

UR - http://www.scopus.com/inward/record.url?scp=0034116108&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034116108&partnerID=8YFLogxK

U2 - 10.1016/S1040-8428(99)00073-6

DO - 10.1016/S1040-8428(99)00073-6

M3 - Article

C2 - 10789491

AN - SCOPUS:0034116108

VL - 33

SP - 169

EP - 185

JO - Critical Reviews in Oncology/Hematology

JF - Critical Reviews in Oncology/Hematology

SN - 1040-8428

IS - 3

ER -